Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022
Thu, May 12, 2022
Wed, May 11, 2022

Tiago Fauth Maintained (ASND) at Buy with Decreased Target to $123 on, May 12th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-123-on-may-12th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Tiago Fauth of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $194 to $123 on, May 12th, 2022.

Tiago has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 0 agree with Tiago's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Tiago


  • Tazeen Ahmad of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $161 on, Tuesday, March 15th, 2022
  • Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $117 on, Thursday, March 3rd, 2022
  • Leland Gershell of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $170 on, Monday, February 14th, 2022

Publication Contributing Sources